Merck Animal Health

Study Reveals Dog Owners and Veterinarians See Challenges in Treating Allergic Skin Disease, Highlighting a Need for a Targeted Rapid Onset Treatment for Dogs of All Ages

June 19, 2026 Merck Animal Health

19 June 2026, Rahway: Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division

Animal Health & Welfare

Merck Animal Health to Acquire TARGAN

June 15, 2026 Merck Animal Health

TARGAN’s innovative high-speed biodevice technology, including its gender identification product WingScanTM, delivers enhanced poultry performance 15 June 2026, Rahway: Merck Animal Health,

Animal Health & Welfare

In Observance of Mental Health Awareness Month, Merck Animal Health Announces Inaugural Veterinary Wellbeing Collective to Help Advance Veterinary Wellbeing

May 6, 2026 Merck Animal Health

As Featured in JAVMA, the Veterinary Wellbeing Collective Brings Together Leaders in the Space to Combat Burnout and Enhance Mental

Animal Health & Welfare

FDA Approves NUMELVI™ (atinvicitinib tablets) for Dogs from Merck Animal Health – The First and Only Second-Generation Janus Kinase (JAK) Inhibitor for the Control of Pruritus Associated with Allergic Dermatitis

February 28, 2026 Merck Animal Health

28 February 2026, Rahway: Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division

Animal Health & Welfare

Merck Animal Health Receives S&P Global Awards for NUMELVI® and INNOVAX® ND-ILT-IBD

February 24, 2026 INNOVAX ND-ILT-IBD, Merck Animal Health, NUMELVI

24 February 2026, Rahway: Merck Animal Health, known as MSD Animal Health outside of the United States and Canada and a